IBD (Inflammatory Bowel Disease) Clinical Trials

16 recruiting

IBD (Inflammatory Bowel Disease) Trials at a Glance

16 actively recruiting trials for ibd (inflammatory bowel disease) are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 8 trials, with the heaviest enrollment activity in Vancouver, Shanghai, and Changchun. Lead sponsors running ibd (inflammatory bowel disease) studies include Changhai Hospital, University of British Columbia, and Children's Hospital Medical Center, Cincinnati.

Browse ibd (inflammatory bowel disease) trials by phase

Treatments under study

About IBD (Inflammatory Bowel Disease) Clinical Trials

Looking for clinical trials for IBD (Inflammatory Bowel Disease)? There are currently 16 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new IBD (Inflammatory Bowel Disease) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about IBD (Inflammatory Bowel Disease) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 116 of 16 trials

Recruiting
Not Applicable

Combining Nutritional Therapy and Anti-TNFα Treatment in Pediatric Patients With Crohn's Disease

IBD (Inflammatory Bowel Disease)Crohn Disease (CD)
University of British Columbia140 enrolled1 locationNCT07314606
Recruiting
Not Applicable

Pre-packaged Low-residue Diet for Bowel Preparation in Patients With Inflammatory Bowel Disease

ColonoscopyIBD (Inflammatory Bowel Disease)
Changhai Hospital1,000 enrolled1 locationNCT07353853
Recruiting

Analysis of Factors Influencing the Quality of Bowel Preparation Before Colonoscopy in IBD Patients

ColonoscopyIBD (Inflammatory Bowel Disease)
Changhai Hospital1,000 enrolled1 locationNCT07335705
Recruiting

Exploring Fecal Calprotectin Levels, Maternal and Infant Microbiota, Infant Health, Nutrition, and Adverse Pregnancy Outcomes With Patient With Inflammatory Bowel Disease

IBD (Inflammatory Bowel Disease)IBD
University of British Columbia80 enrolled2 locationsNCT07385807
Recruiting
Not Applicable

MICI-BIO: Study on Patient With Chronic Inflammatory Bowel Disease

IBD (Inflammatory Bowel Disease)
Meyer Children's Hospital IRCCS15 enrolled1 locationNCT07470502
Recruiting

ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects

IBD (Inflammatory Bowel Disease)Crohn Disease (CD)IBS - Irritable Bowel Syndrome+1 more
American Laboratory Products Company120 enrolled1 locationNCT07089420
Recruiting
Phase 1

A Phase I Study of HW201877 in Healthy Subjects

Healthy ParticipantsIBD (Inflammatory Bowel Disease)
Wuhan Humanwell Innovative Drug Research and Development Center Limited Company104 enrolled1 locationNCT07373457
Recruiting
Not Applicable

Evaluation of the SMART IBD App in Pediatric IBD

IBD (Inflammatory Bowel Disease)Inflammatory Bowel Disease (IBD)
Children's Hospital Medical Center, Cincinnati70 enrolled1 locationNCT07195123
Recruiting
Not Applicable

Diet and Stress Management Combined With Advanced Therapy for Crohn's and Ulcerative Colitis

IBD (Inflammatory Bowel Disease)
Massachusetts General Hospital160 enrolled1 locationNCT07168499
Recruiting
Not Applicable

Study of Treatment With Intensified Omeprazole Treatment to Prevent High Output Stoma 1

Colon CancerStoma - IleostomyHigh Output Stoma+3 more
Medical University of Gdansk80 enrolled2 locationsNCT06917963
Recruiting
Phase 2Phase 3

Evaluate the Efficacy and Safety of Probiotic 6600 as an Adjuvant Therapy for Colitis

ColitisIBD (Inflammatory Bowel Disease)Probiotic Intervention
Changhai Hospital120 enrolled1 locationNCT07047339
Recruiting
Not Applicable

Assessing Interventions of Diet in IBD

IBD (Inflammatory Bowel Disease)Ulcerative Colitis (UC)Crohn Disease (CD)
McMaster University45 enrolled3 locationsNCT06773182
Recruiting

Human and Microbial Determinants of the Onset of IBD Flares

IBD (Inflammatory Bowel Disease)
Viome100 enrolled1 locationNCT06967311
Recruiting
Not Applicable

Infliximab Infusion Rates in Pediatric Inflammatory Bowel Disease

Patient SatisfactionIBD (Inflammatory Bowel Disease)Infliximab+1 more
University Hospital, Akershus60 enrolled1 locationNCT06839820
Recruiting

Sequencing in Inflammatory Bowel Diseases (IBD) Therapy: "the Latium Net".

IBD (Inflammatory Bowel Disease)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS2,700 enrolled1 locationNCT06603337
Recruiting
Phase 2

FAPi-PET Imaging of in Vivo Fibrosis in Inflammatory Bowel Disease Patients

IBD (Inflammatory Bowel Disease)Ulcerative Colitis (UC)Crohn Disease (CD)
Dalia Lartey20 enrolled1 locationNCT06604260